title: Engagement of membrane immunoglobulin enhances Id3 promoter activity in WEHI-231 B lymphoma cells.
abstract: OBJECTIVE
  We have recently shown that engagement of membrane immunoglobulin (mIg) induced upregulation of inhibitor of differentiation 3 (Id3) mRNA, resulting in growth arrest at G1 phase in WEHI-231 cells. In the present study, we examined whether engagement of mIg will affect promoter activity of the Id3 gene in WEHI-231 cells.
  
  
  METHODS
  DNA fragments corresponding to the 5'-flanking region of mId3 gene were amplified by polymerase chain reaction (PCR) using genomic DNA as the template. Three DNA fragments upstream of the transcription start site (+1) of the mId3 gene were subcloned into the luciferase reporter vector PGV-B2. The recombinant constructs were transiently transfected into WEHI-231 cells by an electroporation method. After incubation for 24 h, WEHI-231 cells were stimulated with 10 mg/L anti-IgM or irradiated CD40L-expressing NIH3T3 cells or control NIH3T3 cells for further 24 h, followed by assay for luciferase activity.
  
  
  RESULTS
  The luciferase analysis demonstrated that basal promoter activity of the Id3 gene was found in the region between -200 and +54. The Id3 promoter activity was increased 2-fold following stimulation with anti-IgM, but not CD40L, compared with medium alone.
  
  
  CONCLUSIONS
  The mIg-mediated upregulation of Id3 expression is controlled, at least in part, through transcriptional regulation, as assessed by luciferase assay.
authors.affiliation: Department of Medical Laboratory Science, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, 210002, China. lixiaojun62@yahoo.com.cn
authors.forename: Xiao-jun
authors.initials: XJ
authors.lastname: Li
authors.forename: Kikumi
authors.initials: K
authors.lastname: Hata
authors.forename: Junichiro
authors.initials: J
authors.lastname: Mizuguchi
mesh_terms: D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000494:pharmacology*; D023201:CD40 Ligand / Q000276:immunology; D045744:Cell Line, Tumor; D005786:Gene Expression Regulation; D007075:Immunoglobulin M / Q000276:immunology; D051796:Inhibitor of Differentiation Proteins; D016393:Lymphoma, B-Cell / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D009363:Neoplasm Proteins / Q000235:genetics* / Q000378:metabolism; D010957:Plasmids; D011401:Promoter Regions, Genetic / Q000187:drug effects; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D014162:Transfection; D015854:Up-Regulation
chemical_list: D000888:Antibodies, Anti-Idiotypic; D007075:Immunoglobulin M; D051796:Inhibitor of Differentiation Proteins; D009363:Neoplasm Proteins; D011994:Recombinant Proteins; C044203:anti-IgM; D023201:CD40 Ligand; C075640:ID3 protein, human